by Robert F. Todd III (Editor), Kathleen A. Cooney (Editor), Teresa Hayes (Editor), Martha Pritchett Mims (Editor), Francis P. Worden

Praise for the First Edition:

"As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information by the time the book is [published] it is outdated." [Tumor Board Review] is fresh and just out of the oven I haven't seen any book in oncology like this so far I think my investment in this book was wise and worth it." - Humaid Al-Shamsi, MB(Hon),
BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center

Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists--both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 350 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam.

The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several "tumor board style" illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process.

New to the Second Edition of Tumor Board Review:

• Revised and updated with state-of-the-art knowledge
• Presents the most recent guidelines and management standards in user-friendly format
• Focuses on current indications, use of new drugs, and new treatment of side effects
• Includes new FDA-approved drugs and guidelines
• Offers approximately 350 multiple-choice questions and answers

Product Details